In 2011, the FDA approved Xeomin for cosmetic purposes – the elimination of glabellar (frown) lines. Xeomin is a neurotoxin injection given to patients with medical conditions caused by uncontrollable muscle movement, such as excessive drooling, arm and neck spasms, and eye twitching.
